THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
IMI 11TH CALL LAUNCHED
On 11 December 2013 IMI launched its 11th Call for proposals with topics on osteoarthritis, Alzheimer's, cancer, zoonoses, tools for drug discovery, antimicrobial resistance, & environmental impacts of medicines.
Deadline for applications: 8 April 2014
- 07/03/2014 : RT @Eu2P: Looking for a course on public health impact of ADRs? Apply no later than March 30 for next certificate session. http://t.co/On3q…
- 07/03/2014 : RT @EFPIA: Monday - EFPIA President Chris Viehbacher speaking at @EU_Commission Event - @innovationunion #euic2014 http://t.co/29lrark8v8 @…
- 07/03/2014 : RT @eupatients: APPLICATION @EUPATIents training course for patients and patient representatives medicines R&D now open - apply via http://…